Table 3.

Male recipients—operative and postoperative data

	Recipients from male donors n = 109	Recipients from female donors n = 36	P value
A. Early perioperative data
Ischemic time (min)	163 ± 46	168 ± 57	0.81
Early post‐operative complications (%)	47	56	0.30
Prolonged ionotropics support (%)	35	46	0.16
Days from transplantation to discharge	21 ± 20	26 ± 23	0.07
Days from admission to discharge (total length of stay)	98 ± 138	66 ± 64	0.23
In‐hospital death (%)	21	22	0.53
Cause of in‐hospital death* (%)
Early graft failure	26	63
Coagulopathy/Infection	70	37
Malignancy	0	0
CVA	4	0
B. Long‐term data
Follow‐up adverse events (%)	32	61	0.003
Heart failure (%)	11	36	0.003
Stroke (%)	13	21	0.26
Acute myocardial infarction (%)	5	18	0.03
End stage renal failure (%)	5	29	0.001
Heart retransplantation (%)	2	4	0.75
Cardiac allograft vasculopathy (%)	20	43	0.01
Pacemaker (%)	4	11	0.16
Malignancy (%)	18	14	0.73
New onset peripheral vascular disease (%)	22	39	0.06
Death during follow‐up (%)	21	33	0.12
Cause of death during follow‐up* (%)
Late graft failure	26	33
Coagulopathy/infection	30	25
Malignancy	22	25
CVA	22	17

Values are mean ± SD, or percentage. CVA; cerebrovascular accident.

^* Data are shown for descriptive purposes without a statistical comparison because of small numbers.